Treating a Patient with RA and Hepatitis B or C

Treating a Patient with RA and Hepatitis B or C
This activity has expired. You will be redirected to our Rheumatology/Immunology page shortly to find related content in this specialty.

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, Ohio

Author / Faculty

Dimitrios Vassilopoulos, MD
Assistant Professor of Medicine—Rheumatology
Athens University School of Medicine
Athens, Greece

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated that he may have a relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Leonard Calabrese, DO
	Consulting:	Abbott Laboratories; Elan Pharmaceuticals, Inc.; Genentech, Inc.; Roche Laboratories, Inc.

	Teaching and Speaking:	Genentech, Inc.

The following faculty has indicated he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:

Dimitrios Vassilopoulos, MD

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

Bristol – Myers Squibb Company, Genentech/Biogen Idec

Wyeth Pharmaceuticals

CME Disclaimer